"GlycoVision results featured at ESMO 2024: read the interview here to learn how InterVenn is powering new prognostic and predictive biomarkers!
April 24, 2024
Diagnosing and staging epithelial ovarian cancer by serum glycoproteomic profiling

Get in touch